Leaflet BREVIBLOC 10mg / ml solution for infusion

Product code:
W70513001
Quantity:
1
Indicated for:
cardiac arrhythmias
Route of administration:
infusion
Substance:
esmolol (beta blocker)
ATC
C07AB09 — Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective

Precautions:

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Elderly warning

Older people may have an increased risk of side effects.

Esmolol is a medication used for the treatment of supraventricular tachycardia and acute hypertension, particularly in emergency situations. It is a cardioselective beta-blocker with rapid action, reducing heart rate and blood pressure.

The medication is administered via intravenous infusion under medical supervision, and the dosage is adjusted based on the patient's response.

Common side effects include hypotension, bradycardia, dizziness, and nausea. In rare cases, more severe adverse effects such as heart failure or bronchospasm may occur.

Esmolol is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.

General data about BREVIBLOC 10mg / ml

Substance:
esmolol
Date of latest medicines list:
01-06-2026
Product code:
W70513001
Concentration:
10mg / ml
Pharmaceutical form:
solution for infusion
Quantity:
1
Product type:
Generic medicine
Price:
720.60 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
BAXTER S.A. - BELGIA
Holder:
FARMACEUTICA REMEDIA DISTRIBUTION&LOGISTICS S.R.L. - ROMANIA
Number:
955/2024/01

Concentrations available for esmolol

  • 100mg/10ml
  • 10mg/ml